Home Healthcare Pharmaceuticals Multiple Myeloma Therapeutics Market

Multiple Myeloma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Alkylating Agents, Immunomodulators, Anti-CD38 Monoclonal Antibody, Proteasome Inhibitor, Others), By Distribution Channel (Retail Pharmacies & Drug Stores, Hospital Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR2441DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Multiple Myeloma Therapeutics Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Alkylating Agents
    2. Immunomodulators
    3. Anti-CD38 Monoclonal Antibody
    4. Proteasome Inhibitor
    5. Others
  2. Multiple Myeloma Therapeutics Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Retail Pharmacies & Drug Stores
    2. Hospital Pharmacies
    3. Online Pharmacies
  3. Regional Multiple Myeloma Therapeutics Market
    1. North America
      1. North America Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      2. North America Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
      3. U.S. Multiple Myeloma Therapeutics Market
        1. U.S. Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. U.S. Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      4. Canada Multiple Myeloma Therapeutics Market
        1. Canada Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Canada Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
    2. Europe
      1. Europe Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      2. Europe Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
      3. U.K. Multiple Myeloma Therapeutics Market
        1. U.K. Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. U.K. Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      4. Germany Multiple Myeloma Therapeutics Market
        1. Germany Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Germany Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      5. France Multiple Myeloma Therapeutics Market
        1. France Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. France Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      6. Spain Multiple Myeloma Therapeutics Market
        1. Spain Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Spain Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      7. Italy Multiple Myeloma Therapeutics Market
        1. Italy Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Italy Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      8. Russia Multiple Myeloma Therapeutics Market
        1. Russia Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Russia Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      9. Nordic Multiple Myeloma Therapeutics Market
        1. Nordic Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Nordic Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      10. Benelux Multiple Myeloma Therapeutics Market
        1. Benelux Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Benelux Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      11. Rest of Europe Multiple Myeloma Therapeutics Market
        1. Rest of Europe Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Rest of Europe Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
    3. APAC
      1. APAC Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      2. APAC Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
      3. China Multiple Myeloma Therapeutics Market
        1. China Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. China Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      4. Korea Multiple Myeloma Therapeutics Market
        1. Korea Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Korea Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      5. Japan Multiple Myeloma Therapeutics Market
        1. Japan Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Japan Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      6. India Multiple Myeloma Therapeutics Market
        1. India Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. India Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      7. Australia Multiple Myeloma Therapeutics Market
        1. Australia Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Australia Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      8. Taiwan Multiple Myeloma Therapeutics Market
        1. Taiwan Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Taiwan Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      9. South East Asia Multiple Myeloma Therapeutics Market
        1. South East Asia Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. South East Asia Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      10. Rest of Asia-Pacific Multiple Myeloma Therapeutics Market
        1. Rest of Asia-Pacific Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Rest of Asia-Pacific Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      2. Middle East and Africa Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
      3. UAE Multiple Myeloma Therapeutics Market
        1. UAE Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. UAE Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      4. Turkey Multiple Myeloma Therapeutics Market
        1. Turkey Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Turkey Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      5. Saudi Arabia Multiple Myeloma Therapeutics Market
        1. Saudi Arabia Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Saudi Arabia Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      6. South Africa Multiple Myeloma Therapeutics Market
        1. South Africa Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. South Africa Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      7. Egypt Multiple Myeloma Therapeutics Market
        1. Egypt Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Egypt Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      8. Nigeria Multiple Myeloma Therapeutics Market
        1. Nigeria Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Nigeria Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      9. Rest of MEA Multiple Myeloma Therapeutics Market
        1. Rest of MEA Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Rest of MEA Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
    5. LATAM
      1. LATAM Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      2. LATAM Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
      3. Brazil Multiple Myeloma Therapeutics Market
        1. Brazil Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Brazil Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      4. Mexico Multiple Myeloma Therapeutics Market
        1. Mexico Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Mexico Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      5. Argentina Multiple Myeloma Therapeutics Market
        1. Argentina Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Argentina Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      6. Chile Multiple Myeloma Therapeutics Market
        1. Chile Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Chile Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      7. Colombia Multiple Myeloma Therapeutics Market
        1. Colombia Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Colombia Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
      8. Rest of LATAM Multiple Myeloma Therapeutics Market
        1. Rest of LATAM Multiple Myeloma Therapeutics Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. Alkylating Agents
          2. Immunomodulators
          3. Anti-CD38 Monoclonal Antibody
          4. Proteasome Inhibitor
          5. Others
        2. Rest of LATAM Multiple Myeloma Therapeutics Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
          1. Retail Pharmacies & Drug Stores
          2. Hospital Pharmacies
          3. Online Pharmacies
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.